Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Diabet Med ; 37(7): 1167-1175, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-31278874

RESUMO

AIMS: To assess the intended intensity of Type 2 diabetes care and the factors associated with that intensity of care after the annual monitoring visit in which a new person-centred diabetes consultation model including shared decision making was used. METHODS: We conducted an observational study in 1284 people from 47 general practices and six hospital outpatient clinics. Intensity of care (more, no/minimal change, less) was based on monitoring frequency and referral to other care providers. We used multivariable analyses to determine the factors that were independently associated with intensity of care. Care providers also reported three factors which, in their opinion, determined the intensity of care. RESULTS: After the consultation, 22.8% of people chose more intensive care, 70.6% chose no/minimal change and 6.6% chose less intensive care. Whether care became more intensive vs not/minimally changed was associated with a high educational level (odds ratio 1.65, CI 1.07 to 2.53; P=0.023), concern about illness (odds ratio 1.08; CI 1.00 to 1.17; P=0.045), goal-setting (odds ratio 6.53, CI 3.79 to 11.27; P<0.001), comorbidities (odds ratio 1.12, CI 1.00 to 1.24; P=0.041) and use of oral blood glucose lowering medication (odds ratio 0.59, CI 0.39 to 0.89; P=0.011). Less intensive care vs no/minimal change was associated with lower diabetes distress levels (odds ratio 0.87, CI 0.79 to 0.97; P=0.009). According to care providers, quality of life, lifestyle, person's preferences and motivation, glycaemic control, and self-management possibilities most frequently determined the intended care. CONCLUSIONS: In person-centred diabetes care, the intended intensity of care was associated with both disease- and person-related factors.


Assuntos
Tomada de Decisão Compartilhada , Diabetes Mellitus Tipo 2/tratamento farmacológico , Planejamento de Assistência ao Paciente , Assistência Centrada no Paciente , Idoso , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/psicologia , Gerenciamento Clínico , Escolaridade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Angústia Psicológica
2.
Ned Tijdschr Geneeskd ; 160: D342, 2016.
Artigo em Holandês | MEDLINE | ID: mdl-27405571

RESUMO

Diabetes care is shifting from disease management to personalised care. Internationally, diabetes care providers are advised to integrate the patient's preferences, wishes and possibilities into diabetes care in order to improve its efficiency. The Dutch Diabetes Federation has developed a specifically patient-centred conversation model that can be systematically applied. At an annual appraisal, the physician and the patient make decisions on the treatment goals to set, and on the treatment and professional support needed to achieve these goals. In this way person-centred and efficient care may become reality. The first results of a pilot study are promising. Currently the applicability and added value of the model are being tested on a large scale. The model is more broadly applicable, which means this could be a new perspective for everyone with a chronic disease.


Assuntos
Atenção à Saúde/métodos , Diabetes Mellitus/terapia , Medicina de Precisão/métodos , Humanos , Preferência do Paciente , Médicos
3.
Prostate Cancer Prostatic Dis ; 13(3): 218-27, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20680029

RESUMO

The objective of this study was to determine whether screening for prostate cancer (PC) reduces PC mortality and, if so, whether the required criteria to be introduced as a population-based screening program are satisfied. A literature review was conducted through electronic scientific databases. The screening tests, that is, PSA and digital rectal examination, have limited sensitivity and specificity for detecting PC; screening produces a beneficial stage shift and reduces PC mortality. Nevertheless, PC screening causes a large increase in the cumulative incidence, and the understanding of the economic cost and quality-of-life parameters are limited. PC screening cannot be justified yet in the context of a public health policy.


Assuntos
Exame Retal Digital , Implementação de Plano de Saúde , Antígeno Prostático Específico/sangue , Neoplasias da Próstata/diagnóstico , Humanos , Masculino , Programas de Rastreamento/legislação & jurisprudência , Programas de Rastreamento/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA